Published in Am J Respir Crit Care Med on July 01, 2010
Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal (2012) 1.01
The role of longitudinal cohort studies in epigenetic epidemiology: challenges and opportunities. Genome Biol (2012) 1.00
Indoor fuel exposure and the lung in both developing and developed countries: an update. Clin Chest Med (2012) 0.95
DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways. Am J Respir Cell Mol Biol (2014) 0.91
Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics. Curr Opin Pulm Med (2011) 0.89
Methylated Genes in Sputum Among Older Smokers With Asthma. Chest (2012) 0.87
New developments in the assessment of COPD: early diagnosis is key. Int J Chron Obstruct Pulmon Dis (2014) 0.86
Alu and LINE-1 methylation and lung function in the normative ageing study. BMJ Open (2012) 0.85
Source of biomass cooking fuel determines pulmonary response to household air pollution. Am J Respir Cell Mol Biol (2014) 0.84
Awareness of risk factors among persons at risk for lung cancer, chronic obstructive pulmonary disease and sleep apnea: a Canadian population-based study. Can Respir J (2010) 0.84
Update in chronic obstructive pulmonary disease in 2010. Am J Respir Crit Care Med (2011) 0.82
Transposable elements and their potential role in complex lung disorder. Respir Res (2013) 0.82
Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res (2014) 0.82
Air toxics and epigenetic effects: ozone altered microRNAs in the sputum of human subjects. Am J Physiol Lung Cell Mol Physiol (2014) 0.81
Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells. Am J Respir Cell Mol Biol (2015) 0.79
Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer. J Thorac Oncol (2015) 0.78
The Effects of Air Pollution and Temperature on COPD. COPD (2015) 0.78
Defining and targeting health disparities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Exposure to biomass smoke extract enhances fibronectin release from fibroblasts. PLoS One (2013) 0.76
Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses. Respir Res (2016) 0.76
Update in environmental and occupational medicine 2010. Am J Respir Crit Care Med (2011) 0.76
Non-pharmacological management of chronic obstructive pulmonary disease. Ulster Med J (2015) 0.75
Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study. Respir Res (2016) 0.75
DNA methylation profiling in peripheral lung tissues of smokers and patients with COPD. Clin Epigenetics (2017) 0.75
Socio-economic factors, gender and smoking as determinants of COPD in a low-income country of sub-Saharan Africa: FRESH AIR Uganda. NPJ Prim Care Respir Med (2016) 0.75
Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure. Respir Res (2016) 0.75
Differences in systemic inflammation between cigarette and biomass smoke-induced COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41
Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med (1999) 29.97
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
Chronic obstructive pulmonary disease in non-smokers. Lancet (2009) 6.41
Woodsmoke health effects: a review. Inhal Toxicol (2007) 6.19
MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96
Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res (2000) 3.65
Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol (2006) 3.63
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res (2006) 3.05
Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J (2006) 2.74
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res (2002) 2.56
Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 2.20
Development of carcinoma of the lung as reflected in exfoliated cells. Cancer (1974) 2.20
Respiratory disease in a New Mexico population sample of Hispanic and non-Hispanic whites. Am Rev Respir Dis (1982) 2.14
Pulmonary function changes in children associated with fine particulate matter. Environ Res (1993) 1.91
Symptoms of respiratory illness in young children and the use of wood-burning stoves for indoor heating. Pediatrics (1985) 1.58
GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol Cell Biol (2008) 1.56
Mortality from lung cancer and chronic obstructive pulmonary disease in New Mexico, 1958-82. Am J Public Health (1988) 1.56
Wood smoke: emissions and noncancer respiratory effects. Annu Rev Public Health (1994) 1.43
Difference in airflow obstruction between Hispanic and non-Hispanic White female smokers. COPD (2008) 1.16
Risk of lung cancer from residential heating and cooking fuels in Montreal, Canada. Am J Epidemiol (2006) 1.03
Community woodstove changeout and impact on ambient concentrations of polycyclic aromatic hydrocarbons and phenolics. Environ Sci Technol (2009) 0.92
Urinary levoglucosan as a biomarker of wood smoke exposure: observations in a mouse model and in children. Environ Health Perspect (2008) 0.90
Management of patients with COPD. Lancet (2004) 0.78
DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med (2008) 5.87
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res (2008) 5.05
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest (2007) 4.96
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov (2011) 4.60
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16
MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96
How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle (2009) 3.05
EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res (2011) 2.32
Self-management programmes for COPD: moving forward. Chron Respir Dis (2012) 2.07
New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med (2011) 2.07
Burden of concomitant asthma and COPD in a Medicaid population. Chest (2008) 1.87
Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res (2005) 1.81
Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin Cancer Res (2012) 1.80
Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med (2014) 1.77
The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res (Phila) (2010) 1.73
Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study. J Clin Oncol (2012) 1.72
Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia. Am J Respir Crit Care Med (2011) 1.57
Native American ancestry affects the risk for gene methylation in the lungs of Hispanic smokers from New Mexico. Am J Respir Crit Care Med (2013) 1.54
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2014) 1.52
Development and validation of a new global well-being outcomes rating scale for integrative medicine research. BMC Complement Altern Med (2004) 1.51
MUC1 in macrophage: contributions to cigarette smoke-induced lung cancer. Cancer Res (2013) 1.48
Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Res (2008) 1.46
Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res (2004) 1.45
Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. Cancer Res (2008) 1.43
Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. Cancer Res (2003) 1.39
17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway. Cancer Res (2006) 1.36
Depression and anxiety in women with breast cancer and their partners. Nurs Res (2006) 1.31
Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction. J Clin Invest (2013) 1.29
Potential benefits and problems with computerized prescriber order entry: analysis of a voluntary medication error-reporting database. Am J Health Syst Pharm (2006) 1.29
Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res (2004) 1.28
MS-qFRET: a quantum dot-based method for analysis of DNA methylation. Genome Res (2009) 1.28
Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers. Carcinogenesis (2009) 1.25
Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. Arch Intern Med (2005) 1.24
A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol (2007) 1.23
Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res (2008) 1.22
Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells. Cancer Res (2008) 1.22
Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Mol Cancer Ther (2008) 1.22
Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools. Cancer Res (2007) 1.21
Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Cancer Res (2004) 1.20
Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Mol Pharmacol (2009) 1.18
Difference in airflow obstruction between Hispanic and non-Hispanic White female smokers. COPD (2008) 1.16
Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium. Am J Respir Crit Care Med (2004) 1.14
Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Res (2010) 1.14
Interdependent anxiety and psychological distress in women with breast cancer and their partners. Psychooncology (2007) 1.12
Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer. Cancer Res (2006) 1.12
Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. Cancer Res (2003) 1.10
Prenatal cigarette smoke decreases lung cAMP and increases airway hyperresponsiveness. Am J Respir Crit Care Med (2003) 1.09
An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm (2006) 1.09
The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas. Clin Cancer Res (2011) 1.09
Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung: an evolutionary gift for mounting adaptive protection against lung cancer. Dose Response (2009) 1.07
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. Am J Manag Care (2008) 1.06
Telephone interpersonal counseling with women with breast cancer: symptom management and quality of life. Oncol Nurs Forum (2005) 1.05
IFN-gamma, but not Fas, mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis. J Immunol (2002) 1.04
Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. Carcinogenesis (2005) 1.04
The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death. J Cell Biol (2008) 1.04
Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Int J Cancer (2005) 1.03
Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med (2005) 1.03
Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. Carcinogenesis (2003) 1.02
Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J Immunol (2008) 1.02
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis (2011) 1.02
Deacetylation of p53 induces autophagy by suppressing Bmf expression. J Cell Biol (2013) 1.01
Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model. Cancer Res (2011) 1.01
Response of rats to low levels of sarin. Toxicol Appl Pharmacol (2002) 1.01
MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. Proc Natl Acad Sci U S A (2013) 1.00
Softwares and methods for estimating genetic ancestry in human populations. Hum Genomics (2013) 1.00
Mechanistic basis for nonlinear dose-response relationships for low-dose radiation-induced stochastic effects. Nonlinearity Biol Toxicol Med (2003) 0.98
Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart Lung (2005) 0.98
Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting. Appl Health Econ Health Policy (2014) 0.98
Effects of 10 cigarette smoke condensates on primary human airway epithelial cells by comparative gene and cytokine expression studies. Toxicol Sci (2009) 0.97
Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study. Cancer Res (2011) 0.97
Radiation-induced lung adenocarcinoma is associated with increased frequency of genes inactivated by promoter hypermethylation. Radiat Res (2007) 0.97
Gene promoter hypermethylation in mouse lung tumors. Mol Cancer Res (2006) 0.96
Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. Curr Med Res Opin (2009) 0.96
Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin (2010) 0.96
Chronic inhalation exposure to mainstream cigarette smoke increases lung and nasal tumor incidence in rats. Toxicol Sci (2004) 0.96
Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med (2008) 0.95
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage. Health Serv Res (2008) 0.94
Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers. PLoS One (2012) 0.93
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clin Ther (2007) 0.93